Stock 6827 MEGAPRO BIOMEDICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company MegaPro Biomedical Co., Ltd

Equities

6827

TW0006827009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 12/05/2024 BST 		5-day change 1st Jan Change
24.55 TWD 0.00% Intraday chart for MegaPro Biomedical Co., Ltd +4.25% +0.82%
2022 Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines CI
2022 Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company CI

Business Summary

MegaPro Biomedical Co Ltd is a Taiwan-based company mainly engaged in the development of new drugs with nanomedicine as the core. The Company mainly has two nanotechnology platforms including nanoparticle and nanocell. The Company's products include MPB-1514, MPB-1523, MPB-1734 and MPB-2043. MPB-1514 is mainly used to treat patients with anemia due to chronic kidney disease by intravenous injection. MPB-1523 is mainly used intravenously to diagnose patients with hepatocellular carcinoma. MPB-1734 is mainly used to treat patients with solid tumors by intravenous injection. MPB-2043 is mainly used intravenously to diagnose patients with metastases in the peripheral lymph nodes of the cancerous site.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Nano-sized Iron Oxide IOP Drugs and the Development of Applications of Nano-particles
100.0 %
0 nan % 0 100.0 % -

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Hsien Chih Wang CEO
 Chief Executive Officer - 31/10/14
Yi Hsiang Chiu DFI
 Director of Finance/CFO - 31/12/20
Yuan Hung Hsu BRD
 Director/Board Member - 31/10/14
Yue Fan Chen AUD
 Comptroller/Controller/Auditor - 28/02/17

Members of the board

Members of the board TitleAgeSince
Wei Feng Chiang CHM
 Chairman - 17/09/15
Po Sung Huang BRD
 Director/Board Member - 07/07/21
Hsien Chih Wang CEO
 Chief Executive Officer - 31/10/14
Yuan Hung Hsu BRD
 Director/Board Member - 31/10/14
Chien Ta Huang BRD
 Director/Board Member - 25/08/19
Chih Yung Wu BRD
 Director/Board Member - 09/04/20
Chao Tung Wu BRD
 Director/Board Member - 07/07/21
Chi Chang Hung BRD
 Director/Board Member - 07/07/21
Tsu Sheng Fu BRD
 Director/Board Member - 07/07/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 64,957,903 43,103,552 ( 66.36 %) 0 66.36 %

Company contact information

MegaPro Biomedical Co., Ltd.

Building 52, Suite 526 195, Section 4, Chung Hsing Road

310401, Hsinchu

+

http://www.megaprobio.com
address MegaPro Biomedical Co., Ltd(6827)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MEGAPRO BIOMEDICAL CO., LTD Stock MegaPro Biomedical Co., Ltd
+0.82% 49.12M
MODERNA, INC. Stock Moderna, Inc.
+26.37% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.01% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+46.00% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-5.31% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.34% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.69% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+6.23% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.99% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.38% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6827 Stock
  4. Company MegaPro Biomedical Co., Ltd